Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 807-747-9 | CAS number: 144429-84-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The test article was negative in an OECD 471 compliant Ames test. Neither in an OECD 471 compliant bacterial reverse mutation test nor in an OECD 473 compliant chromosome aberration study appling CHO cells a genotoxic potential of a structural analogue stubstance could be found.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 10 Nov 2017 - 24 Nov 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- liver S9 mix from induced rats
- Test concentrations with justification for top dose:
- 0; 33; 100; 333; 1000; 2500 and 5000 μg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
Due to the insolubility of the test substance in water, DMSO was used as vehicle, which had been demonstrated to be suitable in bacterial reverse mutation tests and for which historical control data are available.
The test substance was weighed and topped up with the chosen vehicle to achieve the required concentration of the stock solution. To achieve a clear solution of the test substance in the vehicle, the test substance preparation was shaken thoroughly. The further concentrations were diluted from the stock solution according to the planned doses. All test substance formulations were prepared immediately before administration. - Untreated negative controls:
- yes
- Remarks:
- sterility control
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: see below
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: triplicates
- Number of independent experiments: two
FOR GENE MUTATION:
- Expression time (cells in growth medium between treatment and selection): After incubation at 37°C for 48 – 72 hours in the dark, the bacterial colonies (his+ revertants) were counted.
METHODS FOR MEASUREMENT OF CYTOTOXICITY
Toxicity detected by a
• decrease in the number of revertants (factor ≤ 0.6)
• clearing or diminution of the background lawn (= reduced his- or trp- background growth)
POSITIVE CONTROLS
The following positive controls were used to check the mutability of the bacteria and the activity of the S9 mix:
With S9 mix
• 2-aminoanthracene (2-AA)
- 2.5 μg/plate, dissolved in DMSO
- strains: TA 1535, TA 100, TA 1537, TA 98
- 60 μg/plate, dissolved in DMSO
- strain: Escherichia coli WP2 uvrA
Without S9 mix
• N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)
- 5 μg/plate, dissolved in DMSO
- strains: TA 1535, TA 100
• 4-nitro-o-phenylenediamine (NOPD)
- 10 μg/plate, dissolved in DMSO
- strain: TA 98
• 9-aminoacridine (AAC)
- 100 μg/plate, dissolved in DMSO
- strain: TA 1537
• 4-nitroquinoline-N-oxide (4-NQO)
- 5 μg/plate, dissolved in DMSO
- strain: E. coli WP2 uvrA - Evaluation criteria:
- The test substance was considered positive in this assay if the following criteria were met:
• A dose-related and reproducible increase in the number of revertant colonies, i.e. at least doubling (bacteria strains with high spontaneous mutation rate, like TA 98, TA 100 and E.coli WP2 uvrA) or tripling (bacteria strains with low spontaneous mutation rate, like TA 1535 and TA 1537) of the spontaneous mutation rate in at least one tester strain either without S9 mix or after adding a metabolizing system.
A test substance was generally considered non-mutagenic in this test if:
• The number of revertants for all tester strains were within the range of the historical negative control data under all experimental conditions in at least two experiments carried out independently of each other. - Species / strain:
- other: all strains used
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- A weak bacteriotox effect (slight decrease in the number of his+ revertants) was observed only with tester strain TA 1535 with S9 mix at a concentration of 5000 μg/plate.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation and time of the determination: Test substance precipitation was found from about 1000 μg/plate onward both with and without S9 mix.
Ames test:
- Signs of toxicity : A weak bacteriotox effect (slight decrease in the number of his+ revertants) was observed only with tester strain TA 1535 with S9 mix at a concentration of 5000 μg/plate. In the preincaubation assay no bacteriotoxic effect (reduced his- or trp- background growth, decrease in the number of his+ or trp+ revertants) was observed up to the highest concentration - Conclusions:
- Under the experimental conditions of this study, the test substance XPDL 920 is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay in the absence and the presence of metabolic activation.
- Executive summary:
The test substance was tested for its mutagenic potential based on the ability to induce point mutations in selected loci of bacterial strains Salmonella typhimurium TA 1535, TA 100, TA 1537, TA 98 and E. coli WP2 uvrA in a reverse mutation assay. The dose range was 33 μg - 5000 μg/plate in standard plate test (SPT) and preincubation test (PIT) both with and without metabolic activation (liver S9 mix from induced rats). Precipitation of the test substance was found from about 1000 μg/plate onward both with and without S9 mix. A weak bacteriotoxic effect was observed only in the SPT with tester strain TA 1535 after the addition of S9 mix at a concentration of 5000 μg/plate. A relevant increase in the number of his+ or trp+ revertants (factor ≥ 2: TA 100, TA 98 and E.coli WP2 uvrA or factor ≥ 3: TA 1535 and TA 1537) was not observed in the standard plate test or in the preincubation test without S9 mix or after the addition of a metabolizing system. Under the experimental conditions of this study, the test substance XPDL 920 is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay in the absence and the presence of metabolic activation.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From June 20th, 1989 to October 20th, 1989
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- yes
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.5265 (The Salmonella typhimurium Bacterial Reverse Mutation Test)
- Deviations:
- yes
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Deviations:
- yes
- Principles of method if other than guideline:
- exception of statistical analysis
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Histidine (his- to his+) and tryptophan (tryp- to tryp+) genes in Salmonella typhimurium and Escherichia coli, respectively
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 fraction of liver from rats induced with Aroclor 1254 and cofactors.
- Test concentrations with justification for top dose:
- 313, 625, 1250, 2500 and 5000 µg/0.1 mLl (with and without microsomal activation)
- Vehicle / solvent:
- Acetone (p.a., Merck, Darmstadt, Germany)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- acetone
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- without S9 mix
- Positive control substance:
- sodium azide
- Remarks:
- Strain: TA100 and TA1535
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- acetone
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- without S9 mix
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- Strain: TA98
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- acetone
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- without S9 mix
- Positive control substance:
- other: (5)-aminoacridine hydrochloride monohydrate
- Remarks:
- Strain: TA1537
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- acetone
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- without S9 mix
- Positive control substance:
- 4-nitroquinoline-N-oxide
- Remarks:
- Strain: E. coli WP2uvrA
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- acetone
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- with S9 mix
- Positive control substance:
- other: 2-aminoanthracene
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- acetone
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- with S9 mix
- Positive control substance:
- cyclophosphamide
- Remarks:
- Strain: TA1535
- Details on test system and experimental conditions:
- The tests are carried out in accordance with the method described by Ames et al. (Ames BN et al. (1973) Proc. Natl. Acad. Sci. USA 70, 782-786; Ames BN et al. (1973) Proc. Natl. Acad. Sci. USA 20, 2281-2285; Ames BN et al. (1975) Mutation Res. 31, 347-364).
The test concentrations were selected on the basis of a preliminary toxicity test which had been carried out with concentrations ranging from 20 to 5000 µg/0.1 mL; accordingly, the concentration of 5000 µg/0.1 mL was retained as the highest in the mutagenicity test and the remaining test concentrations were set at 313, 625, 1250 and 2500 µg/mL.
Each Petri dish contained: 1) approx. 20 mL of minimum agar, 2) 0.1 mL of a solution of the test substance or the vehicle and 0.1 mL of a bacterial culture (in 2.5% nutrient broth) in 2.0 mL of soft agar. For the Salmonella strains the soft agar was supplemented with histidine; for E. coli, the soft agar was supplemented with tryptophan.
In the experiments without microsomal activation 0.5 mL of sodium phosphate buffer was added. In the experiments in which the substance is metabolically activated, the buffer is replaced by 0.5 ml of an activation mixture (S9 mix), which, as already indicated, consisted of the S9 fraction of liver from Sprague-Dawley rats induced with Aroclor 1254 and a solution of co-factors.
In the experiments without and with the addition of microsomal activation mixture three Petri dishes were prepared per strain and per group (i.e. per concentration or per control group). The plates were incubated for about 48 hours at 37 +/-0.5 °C in darkness. At test ending, the number of counted back-mutant colonies in the cultures treated with the various concentrations was compared with controls. - Evaluation criteria:
- The test substance is considered to be positive in this test system if one or both of the following conditions are met:
- at least a reproducible doubling of the mean number of revertants per plate above that of the negative control at any concentration level for one or more of the tester strains TA 98, TA 1535, TA 1537 and E. coli WP2uvrA;
- a reproducible increase of the mean number of revertants per plate for any concentration above that of the negative control by at least a factor of 1.5 for strain TA 100. Generally a concentration-related effect should be demonstrable. - Statistics:
- The data reported include individual numbers of revertants per plate, mean values and standard deviation for each bacterial strain and each concentration.
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- (at the highest test concentration of 5000 µg/0.1 mL the substance precipitated in soft agar)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- (at the highest test concentration of 5000 µg/0.1 mL the substance precipitated in soft agar)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- (at the highest test concentration of 5000 µg/0.1 mL the substance precipitated in soft agar)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- (at the highest test concentration of 5000 µg/0.1 mL the substance precipitated in soft agar)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- (at the highest test concentration of 5000 µg/0.1 mL the substance precipitated in soft agar)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- In the experiments performed without and with microsomal activation, comparison of the number of back-mutant colonies in the controls and the cultures treated with the various concentrations revealed no marked deviations. No evidence of the induction of point mutations by the substance or by the metabolites of the substance formed as a result of microsomal activation was detectable in the strains of S. typhimurium and Escherichia coli used in these experiments.
- Conclusions:
- No evidence of the induction of point mutations by the test item or by the metabolites of the substance formed as a result of microsomal activation was detectable in the strains of S. typhimurium and Escherichia coli used in these experiments.
- Executive summary:
The test substance was tested for mutagenic effects on histidine-auxotrophicmutants of Salmonella typhimurium (strain TA 1535, TA 1537, TA 98 and TA 100) and on a tryptophan-auxotrophic strain of E. coli (WP2 uvrA) according to the OECD TG 471 (1983). The investigations were performed with the following concentrations of the trial substance without and with microsomal activation: 313, 625, 1250, 2500 and 5000 µg/0.1 mL. In order to confirm the results, the experiments were repeated.
For all tested concentrations, without and with microsomal activation,comparison of the number of back-mutant colonies in the controls and the treated bacteria cultures revealed no marked deviations. No evidence of the induction of point mutations by the substance or by the metabolites of the substance formed as a result of microsomal activation was detectable in the strains of S. typhimurium and Escherichia coli used in these experiments. No cytotoxicity was observed up to the highest tested concentration of 5000 µg/0.1 mL, which precipitated in soft agar.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From August 28th, 1992 to February 03rd, 1993
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.5375 (In Vitro Mammalian Chromosome Aberration)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Deviations:
- yes
- Remarks:
- requirements of Article 23 (1,3).
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell micronucleus test
- Target gene:
- The test article was investigated for clastogenic effects on Chinese hamster ovary cells in vitro with and without the addition of an extrinsic metabolic activation system.
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- Cell line: ATCC (Amercian Type Culture Collection) CCL 61 (ovary, Chinese hamster, CHO K1)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Post mitochondrial fraction S9 from Aroclor 1254 induced rat liver
- Test concentrations with justification for top dose:
- Experiments without metabolic activation:
- 18 hours incubation time: 250, 500 and 1000 /µg/mL
- 42 hours incubation time: 15.63, 31.25 and 62.5 /µg/mL
Higher concentrations were not scored according to SOP (strong inhibition of mitotic activity).
Experiments with metabolic activation:
- 3 hours incubation followed by 15 hours recovery period: 250, 500 and 1000 µg/mL
- 3 hours incubation followed by 39 hours recovery period: 250, 500 and 1000 µg/mL - Vehicle / solvent:
- Dimethylsulfoxide
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- The CHO cell line CCL 61 (Chinese hamster ovary cells, CHO) was maintained in culture medium consisting of Nutrient Mixture F-12 supplemented with 10% fetal calf serum and Penicillin/Streptomycin in 75 cm2 tissue-culture (plastic) flasks. The cultures were incubated at 37°C in a humidified atmosphere containing 5% CO2. The cells were passaged twice weekly. The duration of a normal cell cycle determined in the laboratory was 12 - 13 hours. The cell cultures were periodically checked for mycoplasma contamination.
First experiment:
The cells were exposed for 18 hours without metabolic activation to eight concentrations of the test substance. The cells were harvested immediately after treatment. Concentration range: 7.81 - 1000 µg/mL.
Second experiment:
The cells were exposed for three hours with metabolic activation to eight concentrations of the test substance. After removal of the test substance the cells were washed and incubated in new complete culture medium for 15 hours. Concentration range: 7.81 - 1000 µg/mL.
Third experiment:
The cells were exposed for 42 hours without metabolic activation to eight concentrations of the test substance. The cells were harvested immediately after treatment. Concentration range: 7.81 - 1000 µg/mL.
Fourth experiment:
The cells were exposed for three hours with metabolic activation to eight concentrations of the test substance. After removal of the test substance the cells were washed and incubated in new complete culture medium for 39 hours. Concentration range: 7.81 - 1000 µg/mL.
Two hours prior to harvesting, the cultures were treated with Colcemide 0.4 µg/mL to arrest cells in metaphase. The experiment was terminated by hypotonic treatment (0.075 M KCl solution) of the cells, followed by fixation (methanol:acetic acid, 3:1). Slides were air-dried and stained with orcein. - Evaluation criteria:
- Whenever possible two hundred well spread metaphase figures with 19 to 21 centromeres from two cultures (100 metaphases/replicate culture) in the vehicle control and in the treated groups were scored. At least fifty metaphases were scored in the positive controls (25/replicate culture).
The test substance is generally considered to be active in the Chinese Hamster cells if the following conditions are met:
- The percentage of metaphases containing specific aberrations in a treatment group is higher than 6.0 (based on historical negative control range) and differs statistically significant from the respective value of the negative control.
- A concentration-related response should be demonstrable.
The test substance is generally considered to be inactive in the Chinese Hamster cells if the following conditions are met:
- The percentage of metaphases containing specific aberrations in all treatment groups is less than or equal to 6.0 (based on historical negative control range) and does not differ statistically significant from the respective value of the negative control. - Statistics:
- The evaluated numbers of specific aberrations were subjected to statistical analysis. In the preliminary tests the data were assessed for flask effects dependence of cells within each culture) using a chi-square test. The non-significant result of this test means there is no substantial evidence to conclude a flask effect (although a flask effect still might exist). Accordingly a chi-square test for trend was performed modelling all cells in a given experiment as independent. That is, the individual cell is taken as the experimental unit. Consequently the power of the test is substantially increased, resulting in a rather save judgement of the observed effects. The tests were performed based upon the presence of any specific aberration.
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- not clastogenic
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Toxicity test
The results obtained from the toxicity test (mitotic index) are the highest concentration of 1000 µg/mL selected for analysis in the first experiment caused 63.83% suppression of mitotic activity. The highest concentration of 1000 µg/mL selected for analysis in the second experiment caused 13.98% suppression of mitotic activity. In the third experiment with a 42 hours treatment period the highest concentration of 62.5 µg/mL selected for analysis caused 68.80% suppression of mitotic activity. The next higher concentration caused 72% suppression of mitotic activity and was not scored according to SOP. In the fourth experiment (3 hours treatment / 39 hours recovery) the highest concentration of 1000 µg/mL selected for analysis caused no suppression of mitotic activity. Concentrations higher than 1000 µg/mL could not be tested because of strong precipitates in the culture medium.
Mutagenicity study
In the first experiment performed without metabolic activation , 3% of metaphases with specific chromosomal aberrations were detected in the negative control. At the concentrations of 250, 500 and 1000 µg/mL, 3.5%, 1.5% and 2% of cells showed specific chromosomal aberrations.
In the second experiment performed with metabolic activation, 2% of metaphases with specific chromosomal aberrations were seen in the negative control. At the concentrations of 250, 500 and 1000 µg/mL the respective values were 3%, 2% and 1,5%. In the third experiment performed without metabolic activation, 0% of metaphases with specific chromosomal aberrations were detected in the negative control cultures. At the concentrations of 15.63, 31.25 and 62.5 µg/mL the corresponding values were 2%, 0.5% and 3.5%.
In the fourth experiment performed with metabolic activation, 2.5% of metaphases with specific chromosomal aberrations were registered in the negative control cultures. At the concentrations of 250, 500 and 1000 µg/mL the corresponding values were 2.5%, 2% and 3%.
1 out of these 12 values reported above showed no statistically significant difference when compared with their respective negative control. In the third experiment (42 hours treatment without metabolic activation) at the concentration of 62.5 µg/mL a slight, but statistically significant increase in specific chromosomal aberrations was observed (p< 0.01). The incidence of metaphases with aberrations (3.5%) was, however, within the historical negative control range and the criteria for a positive response were not fulfilled. In addition specific chromosomal aberrations like those obtained at the concentration of 62.5 µg/mL are also occasionally found in the negative control experiments. The observed specific chromosomal aberrations were therefore considered to be spontaneous in origin and not related to treatment. Unspecific chromosomal aberrations in the form of chromatid gaps found in all experiments were within the frequency generally observed. - Conclusions:
- No evidence of clastogenic effects was obtained in Chinese hamster ovary cells under in vitro conditions.
- Executive summary:
The test substance was investigated for clastogenic effects on Chinese hamster ovary cells in vitro with and without metabolic activation, according to the OECD TG 473 (1983). In experiments performed without metabolic activation no biologically significant increase in the number of specific chromosome aberrations was observed. In the experiments performed in the presence of a metabolic activation system, no biologically significant increase in the number of specific chromosome aberrations was observed. The number of chromosome aberrations was within the historical control range at all doses assessed. It was concluded that no evidence of clastogenic effects was obtained in Chinese hamster ovary cells under in vitro conditions.
Referenceopen allclose all
EXPERIMENTAL RESULTS
Standard Plate Test:
Mean revertants per plate |
||||||||||
Strain | TA 1535 | TA 100 | TA 1537 | TA 98 | WP2uvrA | |||||
Dose (µg/plate) | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 |
DMSO | 9.3 | 8.7 | 106.7 | 120.3 | 8.3 | 7.3 | 19.7 | 23.0 | 24.0 | 22.0 |
33 | 10.3 | 10.7 | 105.7 | 102.3 | 7.0 | 7.3 | 14.3 | 22.0 | 22.0 | 21.0 |
100 | 13.0 | 9.7 | 98.7 | 119.0 | 6.3 | 5.3 | 17.7 | 24.3 | 22.7 | 26.7 |
333 | 9.0 | 11.0 | 95.0 | 116.3 | 9.7 | 11.7 | 16.3 | 25.7 | 24.7 | 24.7 |
1000 | 9.7 | 12.0 | 100.3 | 107.0 | 10.3 | 8.7 | 16.3 | 23.7 | 21.7 | 26.7 |
2500 | 8.0 | 7.0 | 106.3 | 104.0 | 8.3 | 10.7 | 14.3 | 28.7 | 24.7 | 25.3 |
5000 | 10.3 | 4.3 | 103.3 | 98.7 | 10.3 | 9.7 | 15.7 | 23.7 | 23.7 | 23.3 |
positive control | 4514.0 | 209.3 | 3176.7 | 1659.7 | 763.3 | 85.3 | 922.0 | 854.3 | 740.0 | 86.7 |
Preincubation Test
Mean revertants per plate |
||||||||||
Strain | TA 1535 | TA 100 | TA 1537 | TA 98 | WP2uvrA | |||||
Dose (µg/plate) | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 |
DMSO | 9.0 | 10.3 | 98.7 | 109.7 | 7.0 | 9.3 | 15.7 | 21.7 | 22.0 | 22.3 |
33 | 12.3 | 8.0 | 105.0 | 102.7 | 9.7 | 9.7 | 18.7 | 19.7 | 20.7 | 17.0 |
100 | 10.0 | 9.3 | 98.7 | 109.0 | 9.7 | 7.3 | 13.3 | 23.7 | 19.3 | 25.0 |
333 | 8.0 | 11.0 | 110.0 | 97.7 | 9.7 | 8.7 | 13.0 | 25.0 | 18.3 | 33.7 |
1000 | 7.7 | 8.7 | 97.7 | 107.7 | 8.7 | 7.3 | 18.3 | 29.3 | 16.7 | 23.7 |
2600 | 10.7 | 12.3 | 81.7 | 80.7 | 10.3 | 9.7 | 15.0 | 22.0 | 22.3 | 22.3 |
5200 | 8.7 | 9.0 | 103.7 | 97.0 | 8.3 | 13.3 | 16.7 | 30.0 | 19.0 | 24.0 |
positive control | 3321.3 | 227.0 | 2361.3 | 1677.3 | 842.7 | 85.0 | 1057.0 | 872.0 | 238.3 | 88.7 |
SUMMARY OF RESULTS
Experiment I
TA 1535 | TA 100 | TA 1537 | TA 98 | WP2 uvra | ||||||
Dose (µg/plate) | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 |
Control | 9 | 7 | 137 | 139 | 4 | 7 | 14 | 27 | 15 | 19 |
313 | 9 | 6 | 125 | 133 | 4 | 7 | 17 | 22 | 15 | 16 |
625 | 12 | 9 | 139 | 128 | 6 | 5 | 21 | 35 | 18 | 20 |
1250 | 8 | 5 | 101 | 120 | 3 | 9 | 19 | 33 | 19 | 19 |
2500 | 9 | 5 | 112 | 118 | 4 | 10 | 16 | 34 | 19 | 18 |
5000 | 7 | 6 | 108 | 123 | 3 | 7 | 19 | 28 | 16 | 16 |
positive control | 510 | 234 | 580 | 646 | 446 | 123 | 1107 | 1584 | 240 | 480 |
Experiment II
TA 1535 | TA 100 | TA 1537 | TA 98 | WP2 uvra | ||||||
Dose (µg/plate) | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 |
Control | 11 | 18 | 126 | 151 | 6 | 16 | 18 | 30 | 27 | 24 |
313 | 11 | 16 | 109 | 162 | 5 | 20 | 16 | 37 | 23 | 25 |
625 | 13 | 14 | 118 | 151 | 8 | 22 | 20 | 35 | 26 | 22 |
1250 | 11 | 10 | 127 | 159 | 6 | 16 | 21 | 36 | 34 | 24 |
2500 | 15 | 14 | 137 | 145 | 6 | 13 | 25 | 36 | 22 | 25 |
5000 | 7 | 13 | 136 | 168 | 6 | 13 | 20 | 24 | 24 | 23 |
positive control | 201 | 352 | 737 | 944 | 1198 | 311 | 963 | 1430 | 397 | 558 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
No mutagenic potential of a structural analogue substance was observed in an OECD 474 and GLP compliant study with mice.
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From July 03rd, 1989 to November 01st, 1989
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- Official Journal of the European Communities No L 251 137-139
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.5395 (In Vivo Mammalian Cytogenics Tests: Erythrocyte Micronucleus Assay)
- Version / remarks:
- Guidelines 52 FR 19080 (May 20, 1987; effective June 19, 1987), 798.5395.
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
- Species:
- hamster, Chinese
- Strain:
- other: Chinese hamster (Cricetulus griseus) random outbred strain
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Strain as cited inthe reported: Chinese hamster (Cricetulus griseus) random outbred strain
- Source: CIBA-GEIGY Tierfarm, Sisseln.
- Weights at test initiation:
- tolerability test: females 27-33 g, males 31-33 g
- mutagenicity test: females 23-33 g, males 26-33 g
- Days of acclimatization: at least 3 days
- Diet: standard diet NAFAG No.924, ad libitum
- Water: tap water ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature: 21-23°C
- Humidity: 58-75%
- Air changes: air-conditioned room, no further details
- Photoperiod: 12 hrs/12 hrs - Route of administration:
- oral: gavage
- Vehicle:
- Klucel 0.5%
- Duration of treatment / exposure:
- The animals were sacrificed after 16, 24 and 48 hours post treatment
- Frequency of treatment:
- Single administration by gavage
- Post exposure period:
- 16, 24 and 48 hours (8 female and 8 male animals per sampling time point were sacrificed)
- Dose / conc.:
- 5 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 8
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- 64 mg/kg bw Cyclophosphamide in 20 mL/kg Klucel 0.5% served for positive control substance. the animals were sacrificed after 24 hours following treatment.
- Tissues and cell types examined:
- Bone marrow smears.
- Details of tissue and slide preparation:
- Following sacrifice of the animals, bone marrow was harvested from the shafts of both femurs with fetal calf serum. After centrifugation small drops of the sediment mixture were transferred on the end of a slide, spread out with the aid of a polished cover glass and the preparations were air-dried. Within 24 hours, the slides were stained with undiluted May-Grünwald solution for 3 minutes and then with May-Grünwald solution/water (1:1) for 2 minutes. After being rinsed in distilled water, the slides were left immersed in diluted Giemsa solution (16.6%), for 10 miniutes. After rinsing with distilled water and air-drying, the slides were cleared in Xylene and mounted.
The slides of five animals from each sex showing the best differentiation between mature and polychromatic erythrocytes were selected for scoring. The slides of five female and five male animals each of the negative control group and of the dosage group sacrificed at 16, 24 and 48 hours post-treatment were examined. From the animals of the positive control group which were sacrificed 24 hours after application, the slides of five female and five male animals were scored. 1000 polychromatic erythrocytes per animal each were scored for the incidence of micronuclei. To determine the mitotic activity of the red compartment, the ratio of polychromatic to normochromatic erythrocytes was calculated for each animal by counting a total of 1000 erythrocytes. A low proportion of polychromatic erythrocytes was indicative for a mitosis inhibiting activity of the test substance. - Evaluation criteria:
- A test substance is considered to be active in this test system if a statistically significant increase in the number of polychromatic erythrocytes with micronuclei in comparison with the negative control occurs at any sampling time.
- Statistics:
- Chi-squared test.
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Remarks:
- There was no significant increase in the number of micronucleated polychromatic erythrocytes in the animals treated with 5000 mg/kg bw of the test item as compared with the negative control animals at all sampling times.
- Toxicity:
- yes
- Remarks:
- one case of mortality (male) was reported in the treatment group of 48 hours.
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Tolerability test:
In the tolerability test the maximum dose of 5000 mg/kg bw caused no death in a group of four animals. Therefore, this dose was taken as the highest in the mutagenicity test.
Mutagenicity test:
The mutagenicity test was performed with the dosage of 5000 mg/kg bw.
One male animal died in the treatment group of 48 hours. The animals were treated once with 5000 mg/kg bw test material and bone marrow was harvested 16, 24 and 48 hours thereafter. There was no significant increase in the number of micronucleated polychromatic erythrocytes in the animals treated with the dose of 5000 mg/kg bw of test material as compared with the negative control animals at all three sampling times.
By contrast, the positive control (cyclophosphamide, 64 mg/kg bw, sampling time 24 hours) yielded a marked increase of the percentage of micronucleated cells. Here the mean percentage of polychromatic erythrocytes with micronuclei was 2.0. In comparison with the negative control (0.03 %) this value is highly significant (p <0.05). - Conclusions:
- The test item was tested in an in vivo micronucleus test (MNT) according to the OECD TG 474 (1983) using Chinese hamster. No evidence of mutagenic effects was obtained in Chinese hamsters treatedby gavage with 5000 mg/kg bw test material.
- Executive summary:
The test article was tested in an in vivo micronucleus test (MNT) according to the OECD TG 474 (1983) using Chinese hamster. The test item was administered by single gavage at a dose of 5000 mg/kg bw, which had been selected based on a preliminary tolerability test. The treated animals were sacrificed 16, 24 and 48 hours thereafter. From the bone marrow smears were made and evaluation of any mutagenic effect of the test item on polychromatic erythrocytes as manifested by micronuclei was done.
At all three sampling times, no statistically significant increase in the number of micronucleated polychromatic erythrocytes in comparison with the negative control animals could be evidenced. The respective positive control with cyclophosphamide (64 mg/kg bw) yielded an average of 2.0% polychromatic erythrocytes with micronuclei. This was significantly different from the negative vehicle controls (0.03%). It is concluded that no evidence of mutagenic effects was obtained in Chinese hamsters treated with the test article in the MNT.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Ames Test
The test substance was tested for its mutagenic potential based on the ability to induce point mutations in selected loci of bacterial strains Salmonella typhimurium TA 1535, TA 100, TA 1537, TA 98 and E. coli WP2 uvrA in a reverse mutation assay. The dose range was 33 μg - 5000 μg/plate in standard plate test (SPT) and preincubation test (PIT) both with and without metabolic activation (liver S9 mix from induced rats). A weak bacteriotox effect (slight decrease in the number of his+ revertants) was observed only with tester strain TA 1535 with S9 mix at a concentration of 5000 μg/plate. In the preincaubation assay no bacteriotoxic effect (reduced his- or trp- background growth, decrease in the number of his+ or trp+ revertants) was observed up to the highest concentration. Test substance precipitation was found from about 1000 μg/plate onward both with and without S9 mix. According to the results of the present study, the test substance did not lead to a relevant increase in the number of revertant colonies without S9 mix or after adding a metabolizing system in two experiments carried out independently of each other (standard plate test and preincubation assay). Besides, the results of the negative as well as the positive controls performed in parallel corroborated the validity of this study, since the values fulfilled the acceptance criteria. In this study with and without S9 mix, the number of revertant colonies in the negative controls was within the range of the historical negative control data for each tester strain. In addition, the positive control substances with and without S9 mix induced a significant increase in the number of revertant colonies within the range of the historical positive control data. In conclusion, under the experimental conditions chosen here, it is concluded that the test article is not a mutagenic test substance in the bacterial reverse mutation test in the absence and the presence of metabolic activation.
Assessment of structural analogue substance (EC 406-040-9)
Ames test
In the presence and absence of rat liver S-9-microsomal activation system and at doses of 313-5'000 micrograms per plate, S-typhimurium strains TA 98, TA 100, TA 1535, and TA 1537 as well as E. coli strain WP2uvrA were tested for the induction of base-pair substitutions and frameshift mutations. The study was performed according to OECD testing guideline 471 and under GLP. No evidence of a mutagenic potential associated with the test substance was observed (Ciba-Geigy, 1989).
Chromosome Aberration
Chinese hamster ovary cells were treated in vitro at concentrations up to 1000 µg/ml with and without microsomal activation. The treatments lasted with microsomal activation for 3 hours and the expression periods were 15 hours and 39 hours (treatment periods not included). In the experiment without microsomal activation the combined treatment and expression periods lasted for 18 and 42 hours. The analysis of the metaphases from tests with and without microsomal activation revealed no evidence for a clastogenic effect. The procedure followed OECD Guideline 473 and the principles of GLP (Ciba-Geigy, 1993)
In vivo micronucleus test
The substance was administered orally to groups of 24 female and 24 male animals each in the negative and in the 5'000 mg/kg dose group. The positive control group consisted of 8 female and 8 male animals. Treatment occurred in a single application. 16, 24 and 48 hours after application 8 female and 8 male animals per sampling time were sacrificed and bone-marrow smears were prepared. The procedure followed OECD Guideline 474 and the principles of GLP. No evidence of a mutagenic potential associated with the test substance was observed (Ciba-Geigy, 1989).
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance is not considered to be classified for mutagenicity under Regulation (EC) No 1272/2008, as amended for the eighth time by Regulation (EU) No 2016/218.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.